3,005
Participants
Start Date
April 20, 2019
Primary Completion Date
September 27, 2022
Study Completion Date
September 27, 2022
Elunate®
The recommended dose is 5 mg once daily (1 capsule, each capsule contains 5 mg of fruquintinib); three weeks of continuous drug administration followed by one week of drug free period (4 weeks as one treatment cycle).
Shanghai Dongfang Hospital, Shanghai
Lead Sponsor
Hutchmed
INDUSTRY